Seizure drug gets brain warning
Federal health regulators are warning doctors and patients that an anti-seizure drug from GlaxoSmithKline PLC can cause rare inflammation of the brain and spinal cord.
The Food and Drug Administration said Thursday it is working with the British drugmaker to add new warnings and labeling information to the company’s drug Lamictal.
The agency said it has received reports of 40 cases of aseptic meningitis between 1994, when Lamictal was approved, and last November.
Thirty-five patients needed to be hospitalized, the agency said in a statement. The symptoms usually emerged within the first month and a half of treatment.
From wire dispatches and staff reports